Associated Papers
Stage IV Colorectal Cancer Patients with High Risk Mutation Profiles Survived 16 Months Longer with Individualized Therapies.
Hendricks A et al.
Cancers, 2020
32046290 (PubMed )
Supplement: cancers-12-00393-s001.zip › cancers-698395-2.revision.supplementary_materials › SuppTables_S1-S7_.xlsx › S5_American_patients_mutations
Somatic mutation profiling and HER2 status in KRAS-positive Chinese colorectal cancer patients.
Dong Z et al.
Scientific Reports, 2019
31729406 (PubMed )
Supplement: 41598_2019_53039_MOESM1_ESM.pdf
Megakaryocytes in Myeloproliferative Neoplasms Have Unique Somatic Mutations.
Guo BB et al.
The American Journal of Pathology, 2017
Select a paper to view details